1.Factors Associated with Re-excision after Breast-Conserving Surgery for Early-Stage Breast Cancer.
Woohyun JUNG ; Eunyoung KANG ; Sun Mi KIM ; Dongwon KIM ; Yoonsun HWANG ; Young SUN ; Cha Kyong YOM ; Sung Won KIM
Journal of Breast Cancer 2012;15(4):412-419
PURPOSE: Re-excisions after breast-conserving surgery (BCS) for breast cancer cause delays in the adjuvant treatment, increased morbidity, and leads to poor aesthetic results. Thus, efforts to reduce the re-excision rate are essential. This study aimed to conclusively determine the re-excision rate and the factors associated with re-excision after BCS. METHODS: We retrospectively reviewed the medical records and pathological reports of 711 cases that underwent BCS for early-stage breast cancer. Univariate and multivariate analyses were performed. RESULTS: Of the 711 cases of BCS, 71 (10.0%) required re-excision. Patients in the re-excision group were younger than those in the no re-excision group. Non-palpable lesions, the presence of non-mass-like enhancement at magnetic resonance imaging, multifocality, the presence of a ductal carcinoma in situ (DCIS) component, and an infiltrative tumor border were also significantly associated with re-excision. Multivariate analysis indicated that younger age, non-palpable lesions, multifocal lesions, and the presence of a DCIS component were factors which were independently associated with re-excision. Tumors located in the lower inner quadrant had a relatively high involved resection margin rate as well as a narrow resection margin width, especially at the superior and medial margins. Lateral margins showed a tendency toward a wider resection margin width. CONCLUSION: At our institution, the rate of re-excision was low despite the lack of an intraoperative frozen section. Patients with non-palpable or multifocal tumors, a DCIS component, or those who were younger than 50 years were more likely to require re-excision after BCS. These factors should be considered when planning surgical management of early-stage breast cancer. Positive resection margin rates and margin widths differed on a directional basis based on tumor location, and these differences were considerable.
Breast
;
Breast Neoplasms
;
Carcinoma, Intraductal, Noninfiltrating
;
Frozen Sections
;
Humans
;
Magnetic Resonance Imaging
;
Mastectomy, Segmental
;
Medical Records
;
Multivariate Analysis
;
Retrospective Studies
2.Clinicopathological markers associated with recurrence in ductal carcinoma in situ of breast by age group
Yoonsun CHOI ; Tae Sik HWANG ; Ah Rem JEONG ; Joung Won NA ; Yun Young KIM ; Joon Hyop LEE ; Yoo Seung JUNG ; Sangtae CHOI ; Jin Mo KANG ; Heung Kyu PARK ; Yong Soon CHUN
Korean Journal of Clinical Oncology 2018;14(1):15-20
PURPOSE: In the present study, factors related to the recurrence of breast ductal carcinoma in situ (DCIS) in Korean patients were identified, and the prognostic factors for each age group were explored.METHODS: The subjects were 226 patients who were diagnosed with DCIS by histopathologic examination, and the effect of representative prognostic factors that are known already, including estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2) status, Ki-67 levels, and adjuvant therapy on the recurrence of DCIS was analyzed by using the Cox proportional hazard model.RESULTS: Among the 226 subjects, 11 patients underwent the recurrence of breast cancer. The average follow-up period was 52.7±23.5 months. The average age of the subjects was 50.6±9.3 years. Among the DCIS patients, the recurrence of breast cancer was significantly higher in the ER negative patients and those who have a Ki-67 level over 20%. However, the PR and HER2 status did not significantly affect breast cancer recurrence. The result also showed that only ER negative was a significant factor before the age of 50 years and that only the Ki-67 level over 20% was a significant factor to the patients 50 years of age or older.CONCLUSION: DCIS patients should be appropriately treated and managed depending on their age and clinicopathological factors to prevent the recurrence of DCIS.
Breast Neoplasms
;
Breast
;
Carcinoma, Ductal
;
Carcinoma, Intraductal, Noninfiltrating
;
Estrogens
;
Follow-Up Studies
;
Humans
;
Proportional Hazards Models
;
Receptor, Epidermal Growth Factor
;
Receptors, Progesterone
;
Recurrence